DIVE-MEDICAL TECHNOLOGY

DIVE is a platform consisting of a device and two software modules, DIVE Vision Exam and DIVE AI Vision Screening. The features of each are as follows:

DIVE Vision Exam allows automated testing of oculomotor control, visual acuity, contrast sensitivity, and colour perception. It makes it possible to explore each visual ability in isolation or as a battery of tests, monocularly or binocularly.

DIVE AI Vision Screening performs a comprehensive and automatic analysis of the entire visual function. It includes a battery of audio-guided tests that, once have been finished, the device process with an Artificial Intelligence system and displays the risk of abnormal visual development, strabismus or colour vision defects.

DIVE incorporates features that favor the exploration of visual function in patients who do not cooperate well with standard tests in ophthalmology and optometry:

• The design presents an interface approachable to any patient, especially children, a device that is clearly perceived as harmless and non-invasive. The device itself guides the child in the assessment, so he or she is not distracted by other people or voices.
• The height required to perform the visual examination allows young children to sit on their parents’ lap, so that they are calmer during the process.
• The interface and colors are attractive, smooth, and do not require the intrusion of healthcare personnel, which can be classically perceived as threatening to some children.
• The device has active controls of the attention and quality of the measurements obtained in real time, so that the device itself displays stimuli with music to re-capture the patient’s attention in case he/she has momentarily lost it.
• The evaluation with the device can be performed in any quiet room as long as there is no light or very dim light. In this way it is possible to increase the attention on the screen as it is the only stimulus present for the patient.

DIVE is designed to expand the capabilities of the eye care professional. Obtaining reliable visual function metrics in a matter of minutes is of interest in any clinical scenario. In addition, the autonomous administration of the tests does not require qualified personnel and will help to increase the daily patient portfolio of the practice.

A technician can perform the study of visual skills prior to the consultation. In this way, the ophthalmologist or optician can receive the patient with a lot of information about his or her general visual status, which will favor the patient’s care: less consultation time since we can guide the diagnosis more quickly. Likewise, the number of patients who cannot be scanned is reduced.

Although the first version of DIVE is more focused on pediatric patients, given that the current normative curves go up to 15 years of age, this version can be used in any type of patient to obtain objective measures of visual function.

Currently, adapted versions with more adult stimuli are being developed for non-pediatric patients and the normative curves will be extended to a full age range.

Any alteration in the main visual functions (visual acuity, contrast sensitivity, oculomotor control and colour vision) as well as the presence or absence of strabismus (in the Screening version).

The device is in the final stages of obtaining CE marking. CE marking is the Medical Device manufacturer’s declaration that a product complies with the essential requirements of all relevant European Directives. The Directives describe the safety and performance requirements for medical devices in the European Union (EU).

The device generates customized reports for each of the skills evaluated, showing the values obtained for each metric. Graphs are also shown with the percentile of each parameter with respect to a normative base by age.

It is possible to obtain a PDF report of each exploration that can be printed or sent to an e-mail.